Skip to content
healthcare.dev

Rivastigmine

NDC 70771-1951, Rivastigmine, patch, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1951
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206318
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1951 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE13.3 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
70771-1951-77077119510730 POUCH in 1 CARTON (70771-1951-7) / 24 h in 1 POUCH (70771-1951-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/966d59ea-5cea-4fef-8b96-e0efe885caf4

Use it

Look up 70771-1951 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1951 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1951. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.